Assessment of some biometrics and biochemical parameters in migraine patients

https://doi.org/10.55529/jpdmhd.43.9.17

Authors

  • Faiz Ali Al-Mfrgi High diploma in pathoanalysis-Optics Department-College of Health and Medical Techniques-Al-Door -Northern Technical university-Salahaddin-Iraq.
  • Maan Hasan Salih Assist.prof. Doctorate in molecular biology-Biology Department-Science College-Tikrit University- Salahaddin -Iraq.

Keywords:

Migraine, Serum Minerals, Blood Pressure, Body Mass Index, Iron

Abstract

Background: Migraine is a pulsating and recurrent headache in one or both side. It may be caused by induce of nerves in the brain blood vessels walls and its associates with photophobia. Objectives: Measure of Body mass index (BMI), blood pressure (BP), serum calcium (Ca), magnesium (Mg) and iron (Fe) in migraine patients. Methods: This study performed on 94 persons (64 migraine: 30 control), who visited Al-Duloya General Hospital, Tikrit Educational Hospital, and neurological clinics in Al-Duloya and Tkrit. Also it contains visiting participants to their homes in Salahaddin in Iraq. A socio-demographic characters, length, weight, and BP taken directly. 3-5ml blood sampled for obtaining serum. Biochemical tests analyzed by spectrophotometer in Central laboratory of Tikrit University. The study period extended from 30-7-2023 to 27-9-2023. GraphPrism9 program and T-test used for statistical analysis. Results: Patient age was 34.9(16-63) year. Higher percentages reported in female (79.6%) and family history (68.7%). BMI (29.1±5.5), (27.6±5.3) kg/m2, systolic BP (11.7±1.2), (11.5±1.1), and diastolic BP (7.5±0.8), (7.2±1.0) Cm.Hg, show non-significant elevation in migraine compare with control respectively. Mg reveals significant decrease (1.7±0.7), (2.1±0.6), but Ca (7±0.5), (7.3±0.7) and Iron (82±57), (90±52) mg/dL reveal non-significant decrease in migraine compare with control respectively. Conclusions: BMI and BP show non-significant elevation. While Mg reveals significant decrease, Ca and Iron reveal non-significant decrease in patients.

References

Stovner L, Hagen K, Linde M, and Steiner T. The global prevalence of headache: an update, with analysis of the influences of methodological factors on prevalence estimates. The journal of headache and pain. 2022;23, No. 34. 10.1186/s10194-022-01402-2

"Migraine", National Institute of Neurological Disorders and Stroke. [Online]. Available: https://www.ninds.nih.gov/health-information/disorders/migraine. [Accessed: 11-Feb-2026]

Ministry of Health- Saudia Arabia. Nervous system disease-migraine. 1440. Moh.gov.sa

Ministry of health Saudi Arabia, Ministry Of Health Saudi Arabia. [Online]. Available: https://www.moh.gov.sa/en/HealthAwareness/EducationalContent/Diseases/Nervous-system/Pages/Migraine.aspx. [Accessed: 11-Feb-2026]

Foster E. Migraine. Migraine and Headache Australia Organization. 2021.

American migraine Foundation, (2023), What type of headache do you have?, https://americanmigrainefoundation.org

Hautakangas H., Pirinen M. Genome wide analysis of 102084 migraine cases identifies 123 risk loci and subtype-specific risk alleles. Nature genetics. 2022; 54, 152-160.

Ministry of Health in Lebanon. National Awareness for migraine. 2019. https://www.moph.gov.lb

A. El-Metwally, "The epidemiology of migraine headache in Arab countries: A systemic review", The scientific world journal, vol. 2020. 10.1155/2020/4790254

D. T. Khafaf and B. Meral Koç, "Epidemiology of migraines in Iraqi females: Emphasis on dietary influence", Cureus, vol. 15, no. 8, p. e44080, Aug. 2023. 10.7759/cureus.44080

Simmonds L, Mehta D, Cheema S and Matharu M. Epidemiology of migraine. Handbook of clinical neurology. 2023; 198: p. 31-38. 10.1016/B978-0-12-823356-6.00017-2

CDC, "Centers for disease control and prevention", 06-Feb-2026. [Online]. Available: https://www.cdc.gov. [Accessed: 11-Feb-2026]

D. Khanna, C. Peltzer, P. Kahar, and M. Parmar, "Body mass index (BMI): A screening tool analysis", Review. Cureus, vol. 14, no. 2, 2022. 10.7759/cureus.22119

S. Jahromi, F. Martami, K. Soltani, and M. Togha, "Migraine and obesity: what is the real direction of their association?", vol. 23, pp. 75-84, Jan. 2022. 10.1080/14737175.2023.2173575

S. R. Jahromi, F. Martami, K. Morad Soltani, and M. Togha, "Migraine and obesity: what is the real direction of their association?", Expert Rev. Neurother., vol. 23, no. 1, pp. 75-84, Jan. 2023. 10.1080/14737175.2023.2173575

CDC, "High blood pressure", 14-Feb-2025. [Online]. Available: https://www.cdc.gov/bloodpressure/. [Accessed: 11-Feb-2026]

[Online]. Available: https://www.moh.gov.sa. [Accessed: 11-Feb-2026]

S. Suderhan, A. Sudershan, and K. Singh, Migraine and insulin metabolism linked with glutamate excitotoxicity, vol. 8. India, 2022, pp. 1-004.

W. Robertson, "Chemistry and biochemistry of calcium, Calcium in human biology", pp. 1-26, 2023. 10.1007/978-1-4471-1437-6_1

P. Yin, V. Anttila, K. M. Siewert, A. Palotie, G. Davey Smith, and B. F. Voight, "Serum calcium and risk of migraine: a Mendelian randomization study", Hum. Mol. Genet., vol. 26, no. 4, pp. 820-828, Feb. 2017. 10.1093/hmg/ddw416

M. Aksit, "The impact of magnesium on the glycemic regulation", Int. J. Med. Biochem., 2018. 10.14744/ijmb.2018.52724

J. A. Maier, G. Pickering, E. Giacomoni, A. Cazzaniga, and P. Pellegrino, "Headaches and magnesium: Mechanisms, bioavailability, therapeutic efficacy and potential advantage of magnesium pidolate", Nutrients, vol. 12, no. 9, p. 2660, Aug. 2020. 10.3390/nu12092660

F. Dasa, "Factors affecting iron absorption and mitigation mechanisms: A review", IJASFT, 2018. 10.17352/2455-815X.000033

A. Tayyebi, M. Poursadeghfard, M. Nazeri, and T. Pousadeghfard, "Is there any correlation between migraine attacks and iron deficiency anemia? A case-control study", Int. J. Hematol. Oncol. Stem Cell Res., vol. 13, no. 3, pp. 164-171, July 2019. 10.18502/ijhoscr.v13i3.1276

A. Tarkh and A. Khalaf, "Migraine headache in Shirqat city and the role of some prophylactic drugs", The Med. J. of Tikrit Univer, no. 2, pp. 203-211, 2019.

Ministry of health-Lebanon. Moph.gov.lb. Migraine. 2023.

B. Raffaelli et al., "Sex hormones and calcitonin gene-related peptide in women with migraine: A cross-sectional, matched cohort study", Neurology, vol. 100, no. 17, pp. e1825-e1835, Apr. 2023. 10.1212/WNL.0000000000207114

M. Fila, J. Chojnacki, P. Sobczuk, C. Chojnacki, and J. Blasiak, "Nutrition and calcitonin gene related peptide (CGRP) in migraine", Nutrients, vol. 15, no. 2, p. 289, Jan. 2023. 10.3390/nu15020289

A. Carmine Belin, C. Ran, and L. Edvinsson, "Calcitonin gene-related peptide (CGRP) and cluster headache", Brain Sci., vol. 10, no. 1, p. 30, Jan. 2020. 10.3390/brainsci10010030

D. C. Buse et al., "Comorbid and co-occurring conditions in migraine and associated risk of increasing headache pain intensity and headache frequency: results of the migraine in America symptoms and treatment (MAST) study", J. Headache Pain, vol. 21, no. 1, p. 23, Mar. 2020. 10.1186/s10194-020-1084-y

M. Ajobory, Geographical analysis of relative's marriage in the urban of Salahaddin province. Iraq, 2021.

G. Kardes, A. Hadimli, and A. M. Ergenoglu, "Determination of the frequency of migraine attacks in pregnant women and the ways they cope with headaches: A cross-sectional study", Healthcare (Basel), vol. 11, no. 14, p. 2070, July 2023. 10.3390/healthcare11142070

National Kidney Foundation. Obesity. 2023. USA. https://www.kidney.org/atoz/content/obesity

World Health Organization (WHO). Obesity and overweight. 2023. https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight

S. Alshehri, F. Alshubaily, A. Alzubidi, H. Sonbol, S. Rahimuddin, and E. Jambi, "The correlation between migraine and some biochemical parameters in Saudi females", J Biochem Tech, vol. 10, no. 1, pp. 67-71, 2019.

Harder A, Vijfhuizen L, Henneman P, Van Dick K, Van Duijn C, Terwindt G, and Van den Maagdenberg A. Metabolic profile changes in serum of migraine patients detected using H-NMR spectroscopy. The journal of headache and pain. 2021; 22: 142. 10.1186/s10194-021-01357-w

International journal of advanced research in biological sciences (IJARBS). Darshan Publishers, 2016.

Z. Siva et al., "Determinants of glucose metabolism and the role of NPY the progression of insulin resistance in chronic migraine", Sage journals, 2017. 10.1177/0333102417748928

CGRP gene, Homo sapiens. Gene, 2023.

M. Fila, A. Sobczuk, E. Pawlowska, and J. Blasiak, "Epigenetic connection of the calcitonin gene-related peptide and its potential in migraine", Int. J. Mol. Sci., vol. 23, no. 11, p. 6151, May 2022. 10.3390/ijms23116151

Bove-Fenderson E and Mannstadt M. Hypocalcemic disorder. Best Pract Res Clin Endocrinol Metab. 2018; 32(5): 639-656. 10.1016/j.beem.2018.05.006

Patel U, Kodumuri N, Malik P, Kapoor A, Malhi P, Patel K, Saiyed S, Lovado L, and Kapoor V, Hypocalcemia and vitamin D deficiency amongst migraine patients: A nationwide retrospective study. Medicina. 2019; 55(8), 407. 10.3390/medicina55080407

A. Alzubaidy, F. Alshubaily, S. Alshehri, H. Sonbol, and S. Rahimuddin, "The correlation between migraine and some association biomarkers in Saudi females", J biochem Tech, vol. 10, no. 1, pp. 51-56, 2019.

ATPA1A2 gene, Homo sapiens. Gene, 2023.

M. Lei et al., "Case report: Recurrent hemiplegic migraine attacks accompanied by intractable hypomagnesemia", Front Pediatr, vol. 10, 2022. 10.3389/fped.2022.880242

G. Liamis, E. Hoorn, M. Florentin, and H. Milionis, "An overview of diagnosis and management of drug-induced hypomagnesemia", vol. 9, 2021. 10.1002/prp2.829

B. Sundar, A. G, S. M, and T. Iype, "A study on significance of serum magnesium in migraine", J. Evid. Based Med. Healthc., vol. 4, no. 19, pp. 1102-1107, Mar. 2017. 10.18410/jebmh/2017/216

M. Wiafe and J. Ayenu, A Review of the risk factors for iron deficiency anemia among adolescents in developing countries. Hindawi. 2023. 10.1155/2023/6406286

American society of hematology organization. Iron deficiency anemia. USA, 2021.

S. Rashid, K. Haq Nawaz, M. H. Athar, A. Fakhar, F. Hakeem, and N. Manzoor, "Frequency of iron deficiency anemia in young females with migraine", Pak. Armed Force. Med. J., vol. 72, no. SUPPL-2, pp. S371-74, June 2022. 10.51253/pafmj.v72iSUPPL-2.2977

[Online]. Available: https://doi.org/. [Accessed: 11-Feb-2026].

Published

2024-04-29

How to Cite

Al-Mfrgi, F. A., & Salih, M. H. (2024). Assessment of some biometrics and biochemical parameters in migraine patients. Journal of Prevention, Diagnosis and Management of Human Diseases, 4(1), 103–111. https://doi.org/10.55529/jpdmhd.43.9.17

Article history

  • Received: 20 December 2023
  • Revised: 06 March 2024
  • Accepted: 12 March 2024
  • Published: 29 April 2024